account_id none on file
legal_name Lantern Pharma Inc.
ticker LTRN
cik 1763950
domain lanternpharma.com
linkedin_company_url https://www.linkedin.com/company/lanternpharma
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 35 executives 0 family 0
why_now
we move into 2026, we are positioning to advance our clinical programs, expand our radar platform's commercial reach and revenue potential globally through our new AI Center of Excellence in India, and further strengthen our balance
May 15, 2026 / receipt
callsnone on file
filings
June 30, 2026 and December 31, 2025, the Company has a non-cancelable operating lease for office space in Atlanta, Georgia that requires
filing / Aug 14, 2026 / receipt
Company also leases office space in Dallas, Texas under two leases. One lease is month-to-month, while the other has a contractual term
filing / Aug 14, 2026 / receipt
These increases were partially offset by decreases in travel expenses of approximately $16,000 and rent of approximately $15,000.
filing / May 15, 2026 / receipt
March 31, 2026 and December 31, 2025, the Company has a non-cancelable operating lease for office space in Atlanta, Georgia that requires
filing / May 15, 2026 / receipt
Company also leases office space in Dallas, Texas under two leases. One lease is month-to-month, while the other has a contractual term
filing / May 15, 2026 / receipt
Research and development 1,790,859 3,068,379
ir_statement / Sep 16, 2026 / receipt
Total operating expenses 3,508,090 4,651,900
ir_statement / Sep 16, 2026 / receipt
2x-3x increase in technical team size expected in the coming quarters
ir_statement / Sep 16, 2026 / receipt
Establishing dedicated machine learning and data engineering teams in India
ir_statement / Sep 16, 2026 / receipt
Reduced data infrastructure and talent costs
ir_statement / Sep 16, 2026 / receipt
Advance enrollment for LP-284 in NHL + soft tissue sarcoma and initiate partnering discussions
ir_statement / Sep 16, 2026 / receipt
Expand AI Center of Excellence in India to support technology and service revenue growth
ir_statement / Sep 16, 2026 / receipt
executivesnone on file
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug lantern-pharma-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$